Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Switching and combining dopamine agonists.

H Reichmann1, B Herting, A Mïller

  • 1Department of Neurology, Technical University of Dresden, Dresden, Germany. Heinz.Reichmann@mailbox-tu-dresden.de

Journal of Neural Transmission (Vienna, Austria : 1996)
|December 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients.

Critical care medicine·1992
Same author

Lung function testing: selection of reference values and interpretative strategies.

The American review of respiratory disease·1992
Same author

Defense behavior and coping in an autistic savant: the story of Temple Grandin, PhD.

Psychiatry·1992
Same author

Comparative quantitative evaluation of pleural fibrosis and its effects on pulmonary function in two large asbestos-exposed occupational groups--insulators and sheet metal workers.

Environmental research·1992
Same author

Identification of a repetitive element in the snail Biomphalaria glabrata: relationship to the reverse transcriptase-encoding sequence in LINE-1 transposons.

Gene·1992
Same author

On creativity.

Arthritis and rheumatism·1992
Same journal

Stress and resilience: cortisol hypo-response to acute stress in non-resilient individuals.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same journal

Dopamine supersensitivity psychosis: a critical evaluation of diagnostic validators.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same journal

A refined protocol for the large-scale production of high-quality cerebral organoids.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same journal

Investigating smiling asymmetries in Parkinson's disease through the whistle-smile reflex.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same journal

The German Parkinson expert meetings.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same journal

Changes in leukocytes and CRP in different treatments of major depression.

Journal of neural transmission (Vienna, Austria : 1996)·2026
See all related articles

Switching dopamine agonists is a common Parkinson's disease treatment strategy. This paper offers practical guidance on switching and combining these medications, discussing associated benefits and drawbacks.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Parkinson's disease management frequently involves switching dopamine agonists.
  • Dopamine agonists are crucial for symptomatic relief in Parkinson's disease.

Purpose of the Study:

  • To outline practical strategies for switching between dopamine agonists.
  • To explore the potential of combining different dopamine agonists.
  • To analyze the advantages and disadvantages of combining dopamine agonists.

Main Methods:

  • Review of current clinical practices for dopamine agonist switching.
  • Discussion of pharmacological principles for combining dopamine agonists.
  • Analysis of published data and clinical experience.

Main Results:

Related Experiment Videos

  • Provides a framework for safe and effective dopamine agonist switching.
  • Highlights potential benefits of combination therapy, such as improved symptom control.
  • Identifies risks associated with switching and combination therapy, including adverse events.

Conclusions:

  • Switching dopamine agonists requires careful consideration of individual patient factors.
  • Combination therapy may offer enhanced efficacy but necessitates vigilant monitoring.
  • Optimizing dopamine agonist therapy is key to managing Parkinson's disease progression.